ST6GALNAC2

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, ST6GALNAC2 mutation is significantly associated with the drug of many other genes, with 3 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible ST6GALNAC2-associated genes across cancer lineages are Mirin, 123829, and 50869. Each is linked with ST6GALNAC2 in more than 1 cancer types. Because this analysis shows association rather than direction, both ST6GALNAC2-to-partner and partner-to-ST6GALNAC2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Mirin grouped by ST6GALNAC2-low versus ST6GALNAC2-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ST6GALNAC2→partner) and Y-score (partner→ST6GALNAC2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINEMirin →+0.440+2.646.019.04731
LARGE_INTESTINE123829 →+0.595+2.649.041.04611
LARGE_INTESTINE50869 →+0.459+2.649.030.04611
Each partner links to its Q-omics profile. Showing the 3 strongest of 3 associations by consensus.

Mirin by ST6GALNAC2 expression — LARGE_INTESTINE

Box plot of Mirin in ST6GALNAC2-low vs ST6GALNAC2-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration